SRTANasdaqServices-Health ServicesFiscal year ends December 31
Strata Critical Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$4.54+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $391.41M
- P/E (TTM)
- 8.9
- Dividend yield
- –
Strata Critical Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Health Services companies for comparison
Valuation
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Market Cap | $401.64M | $1.11B |
| Enterprise Value | $378.89M | $1.41B |
| PE Ratio | 8.90 | 22.72 |
| PS Ratio | 1.57 | 1.60 |
| PB Ratio | 1.44 | 3.03 |
| P/TBV Ratio | 3.57 | 4.99 |
Enterprise value
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| EV / Sales | 1.48 | 1.69 |
Income (trailing twelve months)
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Revenue | $255.98M | $561.90M |
| Gross Profit | $52.62M | $173.32M |
| Operating Income | -$20.41M | -$1.81M |
| Pretax Income | -$23.16M | -$572.42K |
| Net Income | $40.22M | -$1.16M |
| EBITDA | -$4.12M | -$20.72K |
| EPS (Diluted) | $0.51 | -$0.02 |
Margins
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Gross Margin | 20.6% | 33.1% |
| Operating Margin | -7.97% | -4.45% |
| Pretax Margin | -9.05% | 1.54% |
| Profit Margin | 15.7% | -2.91% |
| EBITDA Margin | -1.61% | 2.41% |
| FCF Margin | -18.9% | 3.13% |
Returns
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | 16.0% | 1.84% |
| Return on Assets (ROA) | 13.6% | -3.06% |
| Return on Invested Capital (ROIC) | -8.80% | 2.11% |
| Return on Capital Employed (ROCE) | -7.11% | -0.57% |
Growth
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 66.8% | 6.92% |
| Revenue Growth (3Y CAGR) | 57.4% | 10.9% |
| Revenue Growth (5Y CAGR) | 44.6% | 13.2% |
Balance sheet
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $22.75M | $48.71M |
| Net Cash (Debt) | $22.75M | $205.49K |
| Net Cash Per Share | $0.26 | $0.01 |
| Equity (Book Value) | $279.32M | $235.16M |
| Book Value Per Share | $3.16 | $3.48 |
| Tangible Book Value | $112.36M | $703.69K |
| Working Capital | $75.23M | $30.48M |
Financial position
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Current Ratio | 2.64 | 1.40 |
| Quick Ratio | 1.45 | 1.02 |
Cash flow (trailing twelve months)
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$36.03M | $3.10M |
| Capital Expenditures | -$12.42M | -$18.62M |
| Free Cash Flow | -$48.45M | $23.73M |
| FCF Per Share | -$0.55 | $0.37 |
Efficiency
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.87 | 0.87 |
| Revenue Per Employee | $425.92K | $228.48K |
| Profits Per Employee | $66.92K | -$5.75K |
| Employee Count | 601 | 910 |
Dividends and yields
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Earnings Yield | 10.0% | -0.59% |
| FCF Yield | -12.1% | 1.74% |
Shares
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Shares Outstanding | 88,466,800 | 58,282,400 |
| Shares Change (YoY) | 8.11% | 2.68% |
| Float | 69,963,800 | 33,780,100 |
| Shares Held by Insiders | 20.9% | 16.4% |
| Shares Held by Institutions | 63.0% | 85.9% |
Taxes
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Income Tax | $0 | $697.00K |
Scores
| Measure | Strata Critical Medical | Industry median |
|---|---|---|
| Graham Number | $6.02 | $19.59 |
| Graham Upside | 32.6% | -47.5% |
| Altman Z-Score | 4.71 | 2.05 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | 0.05 | -2.71 |
Calculated by StockData from Strata Critical Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.